Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies

Lifelong immunoglobulin replacement is the standard, expensive therapy for severe primary antibody deficiencies. This treatment can be administrated either by intravenous immunoglobulin (IVIG) or subcutaneous infusions (SCIG) and delivered at home or in an out-patient setting. This study aims to det...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beauté, J, Levy, P, Millet, V, Debré, M, Dudoit, Y, Le Mignot, L, Tajahmady, A, Thomas, C, Suarez, F, Pellier, I, Hermine, O, Aladjidi, N, Mahlaoui, N, Fischer, A
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2010
Assuntos:
Translational Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857947/
https://ncbi.nlm.nih.gov/pubmed/20041884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2009.04079.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados